Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: Efficacy of Hi-tACS for Schizophrenia Negative Symptoms [NA]

View source ↗

Summary

A clinical trial is recruiting to assess the efficacy of Hi-tACS (transcranial alternating current stimulation) for negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hi-tACS

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia; Negative Type, Transcranial Alternating Current Stimulation | NA | Status: RECRUITING